CompletedNot Applicable

Maternal and Perinatal Pregnancy Outcome in Women With Heterozygous Hemoglobinopathies

Switzerland540 participantsStarted 2018-04-04

Plain-language summary

This retrospective study aims to investigate pregnancy outcome in women with heterozygous hemoglobinopathies (regarding gestational diabetes, cholestasis and urinary tract infections) and to analyze if there are aggravated maternal and/or perinatal risks.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * pregnant women with or without heterozygous hemoglobinopathy Exclusion Criteria: * refusal of study participation

What they're measuring

gestational diabetes

Timeframe: in the course of pregnancy until delivery

cholestasis in pregnancy

Timeframe: in the course of pregnancy until delivery

urinary tract infection

Timeframe: in the course of pregnancy until delivery

Trial details

NCT IDNCT03837119

SponsorUniversity Hospital, Basel, Switzerland

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-04-11

View on ClinicalTrials.gov More Heterozygous Haemoglobinopathy trials